Dashboard
Manage Tickers

PFE PFIZER INC

NYSE pfizer.com


$ 24.28 $ -0.47 (-1.88 %)    

Monday, 10-Nov-2025 13:52:19 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 622.27 $ 3.48 (0.56 %)
DIA $ 472.93 $ 1.09 (0.23 %)
SPY $ 680.35 $ 3.17 (0.47 %)
TLT $ 89.52 $ 0.04 (0.04 %)
GLD $ 377.88 $ 1.94 (0.52 %)
$ 24.43
$ 24.65
$ 24.27 x 4,684
$ 24.28 x 4,352
$ 23.92 - $ 24.89
$ 19.83 - $ 27.21
117,794,498
na
138.9B
$ 0.50
$ 14.13
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-28-2025 10-Q
2 08-05-2025 06-29-2025 10-Q
3 05-05-2025 03-30-2025 10-Q
4 02-27-2025 12-31-2024 10-K
5 11-04-2024 09-29-2024 10-Q
6 08-05-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 02-22-2024 12-31-2023 10-K
9 11-08-2023 10-01-2023 10-Q
10 08-09-2023 07-02-2023 10-Q
11 05-10-2023 04-02-2023 10-Q
12 02-23-2023 12-31-2022 10-K
13 11-09-2022 10-02-2022 10-Q
14 08-10-2022 07-03-2022 10-Q
15 05-11-2022 04-03-2022 10-Q
16 02-24-2022 12-31-2021 10-K
17 11-12-2021 10-03-2021 10-Q
18 08-12-2021 07-04-2021 10-Q
19 05-13-2021 04-04-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 11-05-2020 09-27-2020 10-Q
22 08-06-2020 06-28-2020 10-Q
23 05-07-2020 03-29-2020 10-Q
24 02-27-2020 12-31-2019 10-K
25 11-07-2019 09-29-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
29 11-08-2018 09-30-2018 10-Q
30 08-09-2018 07-01-2018 10-Q
31 05-10-2018 04-01-2018 10-Q
32 02-22-2018 12-31-2017 10-K
33 11-09-2017 10-01-2017 10-Q
34 08-10-2017 07-02-2017 10-Q
35 05-11-2017 04-02-2017 10-Q
36 02-23-2017 12-31-2016 10-K
37 11-10-2016 10-02-2016 10-Q
38 08-11-2016 07-03-2016 10-Q
39 05-12-2016 04-03-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cogent-biosciences-lead-cancer-drug-cuts-disease-progression-or-death-risk-by-50-in-stomach-cancer-trial
Cogent Biosciences' Lead Cancer Drug Cuts ...
11/10/2025 15:28:05

Cogent Biosciences stock rises as bezuclastinib plus Sutent shows 50% lower progression risk and strong efficacy in Phase 3 GIS...

Core News & Articles
Live On CNBC, Pfizer CEO Albert Bourla Dis...
11/10/2025 14:21:03

mondaycom-metsera-profrac-holding-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Monday.Com, Metsera, Profrac Holding And O...
11/10/2025 11:18:29

why-viasat-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket
Why Viasat Shares Are Trading Higher By Ar...
11/10/2025 09:51:16

pfizer-clinches-10-billion-deal-to-buy-obesity-drug-maker-metsera-outbidding-novo-nordisk-in-fierce-battle-for-weight-loss-market-dominance
Pfizer Clinches $10 Billion Deal To Buy Ob...
11/08/2025 06:56:08

Nvidia CEO Jensen Huang cautioned Elon Musk against underestimating the challenges of semiconductor manufacturing, saying build...

deal-dispatch-from-a-founder-comeback-to-billion-dollar-bids-this-week-in-ma-and-bankruptcy
Deal Dispatch: From A Founder Comeback To ...
11/07/2025 21:22:14

eli-lilly-novo-nordisk-make-weight-loss-drugs-more-affordable-via-medicare-medicaid-trumprx
Eli Lilly, Novo Nordisk Make Weight-Loss D...
11/06/2025 19:10:21

The Trump administration struck deals with Eli Lilly and Novo Nordisk to lower obesity drug prices and expand Medicare coverage...

Core News & Articles
Novo CEO Says Novo And Pfizer Are In Middl...
11/06/2025 19:03:20

https://www.youtube.com/watch?v=uEpKxwMm8-8

pfizer-to-raise-metsera-bid-after-court-denies-attempt-to-block-rival-deal
Pfizer To Raise Metsera Bid After Court De...
11/06/2025 16:40:34

Delaware court denies Pfizer bid to block Metsera's Novo Nordisk deal as FTC flags antitrust risks and Pfizer prepares a hi...

Core News & Articles
'Novo Nordisk again raises bid in takeover...
11/06/2025 16:15:46

https://www.ft.com/content/52216b29-9f22-4338-85a7-eacfc33103a1

Core News & Articles
Reported Earlier, 'Pfizer Matches Novo Bid...
11/06/2025 09:15:19

https://www.ft.com/content/ae3297f3-4dd1-4c8a-b9c5-9c3717d34c52 

Core News & Articles
Reported Earlier, Metsera Issues Statement...
11/06/2025 08:41:37

"Metsera is gratified by the Delaware Court of Chancery's decision to deny Pfizer's request for a temporary restrai...

pfizer-responds-to-delaware-chancery-court-ruling-said-we-remain-confident-in-the-merits-of-our-claims-and-our-belief-that-metsera-has-acted-in-breach-of-its-contractual-obligations
Pfizer Responds To Delaware Chancery Court...
11/05/2025 22:13:12

Core News & Articles
The Wall Street Journal Reported Pfizer Pr...
11/05/2025 21:55:02

Core News & Articles
Novo Nordisk, In A Statement, Says Its Met...
11/05/2025 20:26:03

Core News & Articles
Watching Novo Nordisk, Pfizer, Metsera; Tr...
11/05/2025 20:25:21

Core News & Articles
Metsera Estimates Value Of Pfizer's Latest...
11/05/2025 19:11:32

-Reuters Citing Metsera Letter To Court

Core News & Articles
Pfizer Has Removed Conditions On Sale Of A...
11/05/2025 19:10:18

-Reuters Citing Letter To Court

Core News & Articles
10 Health Care Stocks Whale Activity In To...
11/05/2025 17:35:20

novo-pfizer-are-battling-to-buy-the-future-of-weight-loss--but-viking-already-owns-it
Novo, Pfizer Are Battling To Buy The Futur...
11/04/2025 20:04:42

Viking Global's $45 million investment in Metsera, a biotech company is caught in a bidding war between Pfizer and Novo Nor...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION